Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
NCT01431378 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 92
Last updated 2015-12-11
Summary
This study is being performed to confirm that the new technique, Model-Based Iterative Reconstruction (MBIR) with reduced radiation dose can deliver equivalent image quality for CT scans compared to current techniques (Filtered Back Projection with Adaptive Statistical Iterative Reconstruction (FBP with ASiR) and also to demonstrate that MBIR can improve general image quality characteristics at equivalent radiation dose levels.
Conditions
- Posterior Fossa Hemorrhage
- Lung Cancer
- Flank Pain
- Urolithiasis
- Focal Hepatic Necrosis
Sponsors & Collaborators
-
American College of Radiology - Image Metrix
collaborator INDUSTRY -
GE Healthcare
lead INDUSTRY
Eligibility
- Min Age
- 30 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-05-31
- Completion
- 2015-08-31
Countries
- United States
Study Locations
More Related Trials
-
PET and MRI Imaging of Brain Tumors Using [18F]PARPi
NCT04173104 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of 18F FDG PET/CT TO PET MRI
NCT01986985 ·Status: COMPLETED ·Phase: NA
-
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
NCT01083719 ·Status: UNKNOWN ·Phase: PHASE2
-
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
NCT04417998 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy
NCT05524454 ·Status: COMPLETED ·Phase: NA
-
PET/MR Characterization of Renal Cell Carcinomas
NCT04271254 ·Status: TERMINATED ·Phase: NA
-
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
NCT05844306 ·Status: SUSPENDED ·Phase: NA
-
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
NCT07118176 ·Status: RECRUITING ·Phase: PHASE1
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects
NCT01362712 ·Status: TERMINATED ·Phase: PHASE1
-
Microsphere Localization Using PET/MRI or PET/CT in Patients Following Radioembolization
NCT01744054 ·Status: TERMINATED ·Phase: PHASE1
-
18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia
NCT03116542 ·Status: UNKNOWN ·Phase: NA
-
Comparison of F-18 FDG and C-11 Acetate PET in Multiple Myeloma
NCT03262389 ·Status: COMPLETED ·Phase: PHASE2
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
NCT02422550 ·Status: RECRUITING
-
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
NCT07303725 ·Status: RECRUITING
-
PixelShine vs. Iterative Reconstruction (IR) Processing of CT Images
NCT03033615 ·Status: UNKNOWN ·Phase: NA
-
Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma
NCT02241668 ·Status: WITHDRAWN ·Phase: NA
-
18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma
NCT05826158 ·Status: RECRUITING ·Phase: NA
-
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
NCT05549024 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
NCT02421380 ·Status: RECRUITING ·Phase: NA
-
Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
NCT02051764 ·Status: TERMINATED ·Phase: PHASE2
-
18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.
NCT06335069 ·Status: RECRUITING ·Phase: PHASE2
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA